48
Growth Score
pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
450598
InCephalo Therapeutics is a preclinical stage biotech company developing local treatments for neurological diseases.
About the Company
InCephalo Therapeutics is a preclinical stage biotech company developing local treatments for neurological diseases with a focus on cancers in the brain. The company's C-Lock or Compartment Lock technology retains biologics, that are applied locally behind the blood-brain barrier, in the central nervous system (CNS) and once they leave the
CNS, degrade rapidly in the systemic compartment. Thereby it significantly improves local CNS therapy, a challenging task with regards to achieving high local concentration (for efficacy) and low systemic footprint (to reduce potential side effects).
